Relationship Between SSRI Exposure During Later Life and Clinical and Neuropathological Correlates of Dementia

More on Dementia

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• Statins cut Alzheimer's risk but raise other dementia risks

  Journal of Alzheimer's Disease Reports · 4 Oct 2026

  

• GLP-1 agonists linked to lower dementia risk after COVID-19

  Drug Design, Development and Therapy · 5 Oct 2026

  

• Lewy body disease tracks with cognitive decline and psychosis

  Movement Disorders · 4 Oct 2026